Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 171 | 2024 | 4876 | 10.450 |
Why?
|
Neoplasms, Glandular and Epithelial | 45 | 2017 | 487 | 5.590 |
Why?
|
Endometriosis | 35 | 2024 | 870 | 5.530 |
Why?
|
CA-125 Antigen | 12 | 2021 | 281 | 3.340 |
Why?
|
Dysmenorrhea | 7 | 2024 | 98 | 2.190 |
Why?
|
Leiomyoma | 13 | 2024 | 636 | 1.950 |
Why?
|
Case-Control Studies | 101 | 2024 | 22176 | 1.630 |
Why?
|
Carcinoma, Endometrioid | 8 | 2019 | 276 | 1.460 |
Why?
|
Pelvic Pain | 6 | 2024 | 298 | 1.400 |
Why?
|
Polymorphism, Single Nucleotide | 67 | 2024 | 15936 | 1.280 |
Why?
|
Uterine Neoplasms | 12 | 2024 | 1420 | 1.240 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2019 | 376 | 0.990 |
Why?
|
Cystadenocarcinoma, Serous | 9 | 2023 | 478 | 0.940 |
Why?
|
Genetic Predisposition to Disease | 55 | 2024 | 17904 | 0.920 |
Why?
|
Reproductive History | 7 | 2022 | 211 | 0.910 |
Why?
|
Parity | 14 | 2024 | 927 | 0.880 |
Why?
|
Adenocarcinoma, Clear Cell | 5 | 2019 | 217 | 0.870 |
Why?
|
Menstrual Cycle | 6 | 2022 | 539 | 0.850 |
Why?
|
Female | 232 | 2024 | 392644 | 0.840 |
Why?
|
Adenocarcinoma, Mucinous | 6 | 2019 | 517 | 0.840 |
Why?
|
New England | 10 | 2021 | 1054 | 0.830 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 4 | 2019 | 194 | 0.810 |
Why?
|
Risk Factors | 97 | 2024 | 74206 | 0.780 |
Why?
|
Telomere | 3 | 2020 | 943 | 0.770 |
Why?
|
Intrauterine Devices | 2 | 2021 | 113 | 0.770 |
Why?
|
Hysterectomy | 8 | 2024 | 857 | 0.720 |
Why?
|
Premenopause | 9 | 2019 | 1039 | 0.720 |
Why?
|
Nurses | 10 | 2023 | 2478 | 0.710 |
Why?
|
Contraceptives, Oral | 9 | 2024 | 554 | 0.700 |
Why?
|
Talc | 4 | 2022 | 48 | 0.680 |
Why?
|
Early Detection of Cancer | 7 | 2019 | 3201 | 0.660 |
Why?
|
Sterilization, Tubal | 4 | 2024 | 75 | 0.630 |
Why?
|
Blood Proteins | 1 | 2024 | 1173 | 0.620 |
Why?
|
Postmenopause | 8 | 2021 | 2513 | 0.620 |
Why?
|
Risk | 26 | 2021 | 9610 | 0.610 |
Why?
|
Middle Aged | 116 | 2024 | 220895 | 0.600 |
Why?
|
Menopause | 5 | 2021 | 1646 | 0.590 |
Why?
|
Logistic Models | 31 | 2024 | 13255 | 0.590 |
Why?
|
Humans | 239 | 2024 | 761504 | 0.580 |
Why?
|
Analgesics | 3 | 2021 | 1070 | 0.580 |
Why?
|
Adult | 104 | 2024 | 221177 | 0.560 |
Why?
|
Odds Ratio | 26 | 2024 | 9646 | 0.540 |
Why?
|
Estrogen Replacement Therapy | 6 | 2021 | 1208 | 0.530 |
Why?
|
Telomerase | 5 | 2019 | 745 | 0.530 |
Why?
|
Genetic Variation | 10 | 2016 | 6567 | 0.530 |
Why?
|
Menarche | 3 | 2022 | 532 | 0.510 |
Why?
|
Genotype | 41 | 2019 | 12990 | 0.510 |
Why?
|
Platinum | 1 | 2016 | 220 | 0.490 |
Why?
|
Genome-Wide Association Study | 27 | 2024 | 12690 | 0.480 |
Why?
|
Laparoscopy | 3 | 2024 | 2035 | 0.470 |
Why?
|
Carcinoma | 6 | 2023 | 2330 | 0.450 |
Why?
|
Breast Feeding | 2 | 2020 | 1359 | 0.440 |
Why?
|
Powders | 1 | 2013 | 80 | 0.440 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1844 | 0.430 |
Why?
|
Alleles | 19 | 2022 | 6863 | 0.430 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 6 | 2021 | 2273 | 0.420 |
Why?
|
Prospective Studies | 43 | 2024 | 54425 | 0.420 |
Why?
|
Receptors, Progesterone | 6 | 2016 | 1129 | 0.420 |
Why?
|
Endometrial Neoplasms | 4 | 2017 | 1366 | 0.420 |
Why?
|
Uterine Artery Embolization | 2 | 2023 | 59 | 0.410 |
Why?
|
Mucin-1 | 3 | 2021 | 540 | 0.410 |
Why?
|
Public Opinion | 1 | 2016 | 484 | 0.410 |
Why?
|
Proportional Hazards Models | 25 | 2024 | 12463 | 0.360 |
Why?
|
Smoking | 7 | 2024 | 9053 | 0.360 |
Why?
|
Dietary Fats | 2 | 2020 | 1995 | 0.360 |
Why?
|
Vitamin B 6 | 1 | 2011 | 234 | 0.350 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 28 | 0.350 |
Why?
|
Dairy Products | 2 | 2020 | 490 | 0.350 |
Why?
|
Survival Rate | 9 | 2021 | 12725 | 0.350 |
Why?
|
Aged | 63 | 2024 | 169289 | 0.340 |
Why?
|
Folic Acid | 3 | 2023 | 1323 | 0.340 |
Why?
|
Membrane Proteins | 5 | 2021 | 7856 | 0.340 |
Why?
|
Genetic Loci | 6 | 2017 | 2632 | 0.340 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2010 | 276 | 0.330 |
Why?
|
Proteomics | 4 | 2024 | 3849 | 0.330 |
Why?
|
Pregnancy | 22 | 2023 | 29874 | 0.330 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 127 | 0.330 |
Why?
|
Methionine | 1 | 2011 | 572 | 0.320 |
Why?
|
Breast Neoplasms | 19 | 2022 | 21012 | 0.320 |
Why?
|
Women's Health | 6 | 2022 | 2065 | 0.320 |
Why?
|
Life Style | 3 | 2017 | 3917 | 0.310 |
Why?
|
Vitamin B 12 | 1 | 2011 | 524 | 0.310 |
Why?
|
Survival Analysis | 7 | 2021 | 10090 | 0.310 |
Why?
|
Cohort Studies | 30 | 2024 | 41487 | 0.310 |
Why?
|
Genetic Association Studies | 12 | 2019 | 2735 | 0.310 |
Why?
|
Pain | 4 | 2023 | 5073 | 0.300 |
Why?
|
Young Adult | 27 | 2024 | 59243 | 0.300 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 416 | 0.300 |
Why?
|
Body Size | 2 | 2007 | 463 | 0.290 |
Why?
|
Models, Theoretical | 1 | 2019 | 3575 | 0.290 |
Why?
|
New Hampshire | 6 | 2016 | 175 | 0.290 |
Why?
|
Food | 1 | 2012 | 774 | 0.290 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1886 | 0.280 |
Why?
|
Neoplasm Invasiveness | 12 | 2019 | 3595 | 0.280 |
Why?
|
Anovulation | 1 | 2006 | 54 | 0.280 |
Why?
|
Mendelian Randomization Analysis | 5 | 2019 | 1007 | 0.280 |
Why?
|
Adolescent | 27 | 2024 | 88319 | 0.270 |
Why?
|
Hydrocortisone | 3 | 2019 | 1819 | 0.270 |
Why?
|
Prognosis | 17 | 2021 | 29625 | 0.270 |
Why?
|
Ovulation | 1 | 2007 | 181 | 0.260 |
Why?
|
Alcohol Drinking | 3 | 2018 | 4028 | 0.260 |
Why?
|
Reproduction | 1 | 2010 | 645 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 368 | 0.250 |
Why?
|
Caffeine | 3 | 2024 | 700 | 0.250 |
Why?
|
Hair | 2 | 2018 | 498 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4352 | 0.240 |
Why?
|
Carotenoids | 1 | 2007 | 621 | 0.230 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 2008 | 90 | 0.230 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 257 | 0.230 |
Why?
|
Epidemiologic Research Design | 2 | 2018 | 368 | 0.230 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1993 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2024 | 1934 | 0.230 |
Why?
|
Diet | 6 | 2022 | 8075 | 0.230 |
Why?
|
Europe | 6 | 2017 | 3422 | 0.230 |
Why?
|
Menstruation Disturbances | 1 | 2005 | 143 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2018 | 8547 | 0.230 |
Why?
|
Anticarcinogenic Agents | 2 | 2017 | 250 | 0.220 |
Why?
|
Vitamin D | 3 | 2019 | 3303 | 0.220 |
Why?
|
Menstruation | 1 | 2005 | 307 | 0.220 |
Why?
|
Mucins | 1 | 2007 | 568 | 0.220 |
Why?
|
Quantitative Trait Loci | 6 | 2018 | 2116 | 0.220 |
Why?
|
Follow-Up Studies | 14 | 2022 | 39106 | 0.220 |
Why?
|
BRCA2 Protein | 4 | 2017 | 805 | 0.210 |
Why?
|
Infertility | 3 | 2023 | 654 | 0.210 |
Why?
|
Anthropometry | 1 | 2007 | 1349 | 0.210 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2016 | 350 | 0.210 |
Why?
|
Tea | 1 | 2024 | 288 | 0.210 |
Why?
|
Fertility | 4 | 2022 | 771 | 0.210 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1739 | 0.210 |
Why?
|
Age Factors | 9 | 2021 | 18395 | 0.200 |
Why?
|
Cyclooxygenase 2 | 2 | 2018 | 597 | 0.200 |
Why?
|
Dyspareunia | 1 | 2022 | 48 | 0.200 |
Why?
|
Pesticide Residues | 1 | 2022 | 95 | 0.200 |
Why?
|
Risk Assessment | 16 | 2024 | 23995 | 0.200 |
Why?
|
United States | 29 | 2024 | 72334 | 0.190 |
Why?
|
Progestins | 2 | 2021 | 301 | 0.190 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26125 | 0.190 |
Why?
|
Peritoneal Diseases | 1 | 2021 | 75 | 0.190 |
Why?
|
Transcytosis | 1 | 2021 | 45 | 0.180 |
Why?
|
Phosphoproteins | 1 | 2010 | 2448 | 0.180 |
Why?
|
Infertility, Female | 1 | 2006 | 760 | 0.180 |
Why?
|
Menopause, Premature | 1 | 2022 | 124 | 0.180 |
Why?
|
Aspirin | 4 | 2023 | 3133 | 0.180 |
Why?
|
Eating | 2 | 2020 | 1539 | 0.180 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2021 | 155 | 0.170 |
Why?
|
Pesticides | 1 | 2022 | 296 | 0.170 |
Why?
|
Urinary Incontinence, Stress | 1 | 2022 | 181 | 0.170 |
Why?
|
Action Potentials | 1 | 2007 | 1834 | 0.170 |
Why?
|
Mexican Americans | 1 | 2021 | 167 | 0.170 |
Why?
|
Coffee | 1 | 2024 | 593 | 0.170 |
Why?
|
Polymorphism, Genetic | 5 | 2013 | 4243 | 0.170 |
Why?
|
DNA, Neoplasm | 3 | 2015 | 1745 | 0.170 |
Why?
|
Antioxidants | 1 | 2007 | 1668 | 0.170 |
Why?
|
Leisure Activities | 1 | 2021 | 308 | 0.170 |
Why?
|
Dietary Supplements | 2 | 2014 | 3415 | 0.170 |
Why?
|
Mastocytosis, Systemic | 1 | 2021 | 103 | 0.170 |
Why?
|
Incidence | 14 | 2024 | 21353 | 0.160 |
Why?
|
Estrogen Receptor alpha | 2 | 2016 | 582 | 0.160 |
Why?
|
Labor Stage, First | 1 | 2019 | 20 | 0.160 |
Why?
|
Models, Neurological | 1 | 2007 | 1767 | 0.160 |
Why?
|
Labor Onset | 1 | 2019 | 17 | 0.160 |
Why?
|
Autoantibodies | 2 | 2018 | 2116 | 0.160 |
Why?
|
Receptors, Androgen | 1 | 2005 | 1079 | 0.160 |
Why?
|
Oncogene Proteins | 2 | 2022 | 718 | 0.160 |
Why?
|
Recreation | 2 | 2016 | 125 | 0.160 |
Why?
|
Haplotypes | 5 | 2009 | 2713 | 0.160 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 783 | 0.160 |
Why?
|
Area Under Curve | 3 | 2017 | 1638 | 0.160 |
Why?
|
Thymidylate Synthase | 1 | 2018 | 74 | 0.160 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 97 | 0.160 |
Why?
|
Glucuronosyltransferase | 1 | 2019 | 132 | 0.160 |
Why?
|
Dehydroepiandrosterone | 1 | 2019 | 258 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9280 | 0.150 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.150 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 57 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2021 | 1241 | 0.150 |
Why?
|
Oligomenorrhea | 1 | 2017 | 42 | 0.150 |
Why?
|
Nutrition Assessment | 1 | 2021 | 728 | 0.150 |
Why?
|
Tissue Array Analysis | 2 | 2016 | 550 | 0.150 |
Why?
|
Pelvis | 1 | 2022 | 732 | 0.140 |
Why?
|
Specimen Handling | 1 | 2022 | 702 | 0.140 |
Why?
|
Immunoglobulin A | 1 | 2021 | 978 | 0.140 |
Why?
|
5-Methylcytosine | 1 | 2017 | 148 | 0.140 |
Why?
|
Exercise | 3 | 2021 | 5890 | 0.140 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 200 | 0.140 |
Why?
|
Tasmania | 1 | 2016 | 4 | 0.140 |
Why?
|
Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.140 |
Why?
|
Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
Aged, 80 and over | 18 | 2021 | 58976 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2023 | 11121 | 0.140 |
Why?
|
Abdominal Pain | 1 | 2023 | 1071 | 0.140 |
Why?
|
Feeding Behavior | 2 | 2014 | 3188 | 0.140 |
Why?
|
Biotinidase | 1 | 2016 | 17 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2019 | 341 | 0.140 |
Why?
|
Epidemiologic Studies | 4 | 2023 | 675 | 0.140 |
Why?
|
Receptors, Calcitriol | 1 | 2019 | 360 | 0.140 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.130 |
Why?
|
Metformin | 1 | 2024 | 906 | 0.130 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 583 | 0.130 |
Why?
|
Multivariate Analysis | 8 | 2018 | 12059 | 0.130 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1733 | 0.130 |
Why?
|
Fallopian Tube Diseases | 1 | 2016 | 60 | 0.130 |
Why?
|
Meta-Analysis as Topic | 6 | 2017 | 1380 | 0.130 |
Why?
|
Neoplasm Proteins | 5 | 2019 | 3617 | 0.130 |
Why?
|
Comorbidity | 4 | 2024 | 10508 | 0.130 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 294 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 533 | 0.130 |
Why?
|
Computer Simulation | 2 | 2018 | 6240 | 0.130 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 701 | 0.130 |
Why?
|
Codon, Terminator | 1 | 2015 | 124 | 0.130 |
Why?
|
RNA Editing | 1 | 2016 | 151 | 0.120 |
Why?
|
Hyperthyroidism | 1 | 2017 | 294 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 302 | 0.120 |
Why?
|
Genitalia, Female | 1 | 2016 | 147 | 0.120 |
Why?
|
NF-kappa B | 2 | 2014 | 2490 | 0.120 |
Why?
|
Abortion, Induced | 1 | 2021 | 462 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1567 | 0.120 |
Why?
|
Genital Diseases, Female | 1 | 2016 | 192 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3245 | 0.120 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1814 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13639 | 0.120 |
Why?
|
Dihydrouracil Dehydrogenase (NADP) | 1 | 2014 | 17 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 751 | 0.120 |
Why?
|
Mandibular Diseases | 1 | 2015 | 119 | 0.120 |
Why?
|
Massachusetts | 6 | 2016 | 8830 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2020 | 819 | 0.120 |
Why?
|
Regression Analysis | 3 | 2018 | 6343 | 0.120 |
Why?
|
Linkage Disequilibrium | 4 | 2009 | 1998 | 0.120 |
Why?
|
Parturition | 1 | 2018 | 445 | 0.110 |
Why?
|
Exercise Therapy | 1 | 2021 | 929 | 0.110 |
Why?
|
Prostatic Neoplasms | 5 | 2019 | 11118 | 0.110 |
Why?
|
Ovary | 3 | 2013 | 959 | 0.110 |
Why?
|
Alternative Splicing | 2 | 2016 | 1093 | 0.110 |
Why?
|
Motor Activity | 2 | 2021 | 2715 | 0.110 |
Why?
|
Body Mass Index | 9 | 2019 | 12953 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1784 | 0.110 |
Why?
|
Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
Boston | 2 | 2022 | 9326 | 0.110 |
Why?
|
Acetaminophen | 2 | 2017 | 554 | 0.110 |
Why?
|
Diethylstilbestrol | 1 | 2013 | 87 | 0.110 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3085 | 0.110 |
Why?
|
Triglycerides | 1 | 2021 | 2461 | 0.110 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 86 | 0.110 |
Why?
|
Cystadenoma, Serous | 1 | 2014 | 100 | 0.110 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2016 | 284 | 0.110 |
Why?
|
4-Butyrolactone | 1 | 2013 | 61 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14605 | 0.110 |
Why?
|
History, 20th Century | 1 | 2021 | 2767 | 0.110 |
Why?
|
Environmental Exposure | 3 | 2019 | 4486 | 0.110 |
Why?
|
Sexually Transmitted Diseases | 1 | 2019 | 662 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 328 | 0.110 |
Why?
|
Acrylamide | 1 | 2013 | 59 | 0.100 |
Why?
|
Protective Agents | 1 | 2014 | 150 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Lignans | 1 | 2013 | 84 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 192 | 0.100 |
Why?
|
British Columbia | 2 | 2024 | 241 | 0.100 |
Why?
|
Lactose | 1 | 2012 | 95 | 0.100 |
Why?
|
Hypothyroidism | 1 | 2017 | 668 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.100 |
Why?
|
Fallopian Tubes | 1 | 2013 | 177 | 0.100 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2012 | 68 | 0.100 |
Why?
|
Drug Resistance, Multiple | 1 | 2013 | 255 | 0.100 |
Why?
|
Gene Amplification | 1 | 2017 | 1089 | 0.100 |
Why?
|
Estradiol | 3 | 2023 | 1937 | 0.100 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.100 |
Why?
|
Confidence Intervals | 3 | 2009 | 2927 | 0.100 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2382 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 3802 | 0.100 |
Why?
|
BRCA1 Protein | 2 | 2017 | 1155 | 0.100 |
Why?
|
Alveolar Bone Loss | 1 | 2015 | 390 | 0.100 |
Why?
|
ROC Curve | 2 | 2017 | 3579 | 0.100 |
Why?
|
Neoplasms | 2 | 2019 | 22170 | 0.100 |
Why?
|
Body Height | 1 | 2018 | 1570 | 0.100 |
Why?
|
Gene Expression Profiling | 7 | 2017 | 9420 | 0.100 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2013 | 418 | 0.090 |
Why?
|
Luteal Phase | 1 | 2011 | 138 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2872 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2413 | 0.090 |
Why?
|
Lipids | 1 | 2022 | 3341 | 0.090 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6814 | 0.090 |
Why?
|
Nuclear Proteins | 3 | 2016 | 5796 | 0.090 |
Why?
|
Inflammation | 4 | 2024 | 10773 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 736 | 0.090 |
Why?
|
Vegetables | 3 | 2022 | 1195 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2023 | 6484 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2022 | 2020 | 0.090 |
Why?
|
Registries | 3 | 2023 | 8224 | 0.090 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2013 | 328 | 0.090 |
Why?
|
Stress, Psychological | 2 | 2018 | 4481 | 0.090 |
Why?
|
Estrogens | 3 | 2023 | 1522 | 0.090 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2010 | 63 | 0.090 |
Why?
|
ABO Blood-Group System | 1 | 2012 | 380 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5305 | 0.090 |
Why?
|
Obesity | 4 | 2019 | 12947 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1745 | 0.080 |
Why?
|
Population Surveillance | 2 | 2017 | 2598 | 0.080 |
Why?
|
Vehicle Emissions | 1 | 2014 | 656 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1403 | 0.080 |
Why?
|
Calcium, Dietary | 1 | 2012 | 529 | 0.080 |
Why?
|
Waist-Hip Ratio | 1 | 2010 | 518 | 0.080 |
Why?
|
Body Fat Distribution | 1 | 2010 | 245 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2020 | 1390 | 0.080 |
Why?
|
Estrone | 1 | 2010 | 234 | 0.080 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3877 | 0.080 |
Why?
|
Androgens | 1 | 2016 | 1286 | 0.080 |
Why?
|
Abdominal Fat | 1 | 2010 | 221 | 0.080 |
Why?
|
DNA Ligases | 1 | 2009 | 82 | 0.080 |
Why?
|
Actins | 1 | 2016 | 2050 | 0.080 |
Why?
|
Microsatellite Repeats | 1 | 2011 | 784 | 0.080 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2009 | 114 | 0.080 |
Why?
|
Gene Frequency | 4 | 2016 | 3606 | 0.080 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2008 | 87 | 0.080 |
Why?
|
Aromatase | 1 | 2008 | 147 | 0.080 |
Why?
|
Probability | 2 | 2018 | 2477 | 0.080 |
Why?
|
Heterozygote | 5 | 2015 | 2787 | 0.080 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9606 | 0.080 |
Why?
|
Neurons | 1 | 2007 | 9463 | 0.080 |
Why?
|
Health Surveys | 4 | 2021 | 4061 | 0.080 |
Why?
|
Australia | 4 | 2014 | 1250 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2019 | 2056 | 0.070 |
Why?
|
Diet, Mediterranean | 1 | 2014 | 740 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 535 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2022 | 2330 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2917 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2825 | 0.070 |
Why?
|
Quality of Life | 3 | 2023 | 13367 | 0.070 |
Why?
|
Waist Circumference | 1 | 2010 | 935 | 0.070 |
Why?
|
Social Class | 1 | 2016 | 2004 | 0.070 |
Why?
|
Hemoglobins | 1 | 2013 | 1525 | 0.070 |
Why?
|
MicroRNAs | 3 | 2011 | 3816 | 0.070 |
Why?
|
Genes, p53 | 1 | 2009 | 712 | 0.070 |
Why?
|
Signal Transduction | 5 | 2019 | 23445 | 0.070 |
Why?
|
Glutathione Transferase | 1 | 2008 | 565 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2803 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3208 | 0.070 |
Why?
|
Chronic Disease | 2 | 2018 | 9318 | 0.070 |
Why?
|
Lymphocytes | 1 | 2014 | 2612 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1054 | 0.060 |
Why?
|
Homozygote | 4 | 2014 | 1776 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3778 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3763 | 0.060 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15500 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6075 | 0.060 |
Why?
|
Stromal Cells | 1 | 2010 | 1330 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2895 | 0.060 |
Why?
|
Melanoma | 2 | 2021 | 5709 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2781 | 0.060 |
Why?
|
Mutation | 5 | 2017 | 30052 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3080 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2022 | 12795 | 0.060 |
Why?
|
Age Distribution | 2 | 2007 | 2880 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5769 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2021 | 5821 | 0.050 |
Why?
|
Fertilization in Vitro | 1 | 2011 | 1292 | 0.050 |
Why?
|
Proteins | 1 | 2018 | 6032 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4511 | 0.050 |
Why?
|
DNA Methylation | 4 | 2023 | 4398 | 0.050 |
Why?
|
Body Weight | 2 | 2011 | 4618 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2244 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2008 | 3416 | 0.050 |
Why?
|
Algorithms | 3 | 2020 | 14031 | 0.050 |
Why?
|
Child | 6 | 2023 | 80153 | 0.050 |
Why?
|
Particulate Matter | 1 | 2014 | 2605 | 0.050 |
Why?
|
Cyclin E | 1 | 2022 | 156 | 0.050 |
Why?
|
Sex Factors | 1 | 2016 | 10552 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2947 | 0.050 |
Why?
|
Thionucleotides | 1 | 2002 | 112 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4936 | 0.050 |
Why?
|
Genes, bcl-2 | 1 | 2002 | 119 | 0.050 |
Why?
|
Prevalence | 4 | 2024 | 15732 | 0.050 |
Why?
|
Social Support | 1 | 2011 | 2171 | 0.050 |
Why?
|
Embryo Implantation | 1 | 2023 | 270 | 0.050 |
Why?
|
Age of Onset | 2 | 2006 | 3305 | 0.050 |
Why?
|
Neutrophils | 1 | 2014 | 3767 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2518 | 0.050 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2000 | 86 | 0.040 |
Why?
|
Air Pollution | 1 | 2014 | 2359 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4920 | 0.040 |
Why?
|
Air Pollutants | 1 | 2014 | 2896 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.040 |
Why?
|
Glutens | 1 | 2022 | 240 | 0.040 |
Why?
|
Glycemic Index | 1 | 2022 | 396 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7212 | 0.040 |
Why?
|
Time Factors | 6 | 2019 | 39967 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2016 | 1787 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3810 | 0.040 |
Why?
|
Menorrhagia | 1 | 2019 | 59 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 629 | 0.040 |
Why?
|
Gestational Age | 2 | 2018 | 3577 | 0.040 |
Why?
|
Mycoplasma genitalium | 1 | 2019 | 12 | 0.040 |
Why?
|
Cervical Ripening | 1 | 2019 | 18 | 0.040 |
Why?
|
Genetic Markers | 2 | 2016 | 2601 | 0.040 |
Why?
|
Leucine | 1 | 2000 | 548 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2002 | 461 | 0.040 |
Why?
|
Trans Fatty Acids | 1 | 2020 | 155 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6766 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 702 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6935 | 0.040 |
Why?
|
Endometrium | 1 | 2021 | 403 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2021 | 1060 | 0.040 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2019 | 96 | 0.040 |
Why?
|
Emergency Nursing | 1 | 1998 | 42 | 0.040 |
Why?
|
Dietary Fiber | 1 | 2022 | 759 | 0.040 |
Why?
|
Hydro-Lyases | 1 | 2018 | 94 | 0.040 |
Why?
|
Human papillomavirus 18 | 1 | 2019 | 125 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3673 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1899 | 0.040 |
Why?
|
Birth Weight | 1 | 2006 | 2103 | 0.040 |
Why?
|
Self Report | 2 | 2021 | 3724 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 80636 | 0.040 |
Why?
|
Herpesvirus 2, Human | 1 | 2019 | 191 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1595 | 0.040 |
Why?
|
Crisis Intervention | 1 | 1998 | 109 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2022 | 891 | 0.040 |
Why?
|
Labor, Induced | 1 | 2019 | 151 | 0.040 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 190 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 1999 | 328 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10766 | 0.040 |
Why?
|
Genome, Human | 1 | 2010 | 4425 | 0.040 |
Why?
|
Chlamydia trachomatis | 1 | 2019 | 239 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 535 | 0.040 |
Why?
|
Fruit | 1 | 2022 | 1160 | 0.040 |
Why?
|
Human papillomavirus 16 | 1 | 2019 | 267 | 0.040 |
Why?
|
Breast | 1 | 2006 | 1967 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1603 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4414 | 0.030 |
Why?
|
Hypertension | 1 | 2017 | 8540 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2000 | 376 | 0.030 |
Why?
|
Gene Expression | 2 | 2023 | 7581 | 0.030 |
Why?
|
Disease Progression | 3 | 2021 | 13506 | 0.030 |
Why?
|
Telomere-Binding Proteins | 1 | 2017 | 119 | 0.030 |
Why?
|
Tyrosine | 1 | 2000 | 1440 | 0.030 |
Why?
|
Nuchal Cord | 1 | 2015 | 5 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1738 | 0.030 |
Why?
|
Geography | 1 | 2018 | 656 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2000 | 910 | 0.030 |
Why?
|
Dioxygenases | 1 | 2017 | 345 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1008 | 0.030 |
Why?
|
Saliva | 1 | 2019 | 828 | 0.030 |
Why?
|
Nursing Staff, Hospital | 1 | 1998 | 348 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1242 | 0.030 |
Why?
|
Cooperative Behavior | 2 | 2013 | 1505 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13380 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 749 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2020 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 16981 | 0.030 |
Why?
|
Receptors, Estrogen | 2 | 2013 | 2208 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2014 | 117 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6346 | 0.030 |
Why?
|
Protein Kinases | 1 | 2000 | 1608 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2019 | 1119 | 0.030 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
Environment | 1 | 2019 | 1123 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 306 | 0.030 |
Why?
|
Epoxy Compounds | 1 | 2013 | 137 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3113 | 0.030 |
Why?
|
Vaccination | 2 | 2022 | 3384 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14666 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11742 | 0.030 |
Why?
|
Prostatectomy | 1 | 2000 | 1824 | 0.030 |
Why?
|
Testosterone | 1 | 2023 | 2472 | 0.020 |
Why?
|
Male | 8 | 2019 | 360804 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 463 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3826 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2021 | 1670 | 0.020 |
Why?
|
Denmark | 1 | 2014 | 771 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 1999 | 1051 | 0.020 |
Why?
|
Depression | 2 | 2023 | 8124 | 0.020 |
Why?
|
Luciferases | 1 | 2013 | 714 | 0.020 |
Why?
|
Alcoholic Beverages | 1 | 2013 | 264 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 993 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10209 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2015 | 1529 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 832 | 0.020 |
Why?
|
Biological Transport | 1 | 2015 | 2091 | 0.020 |
Why?
|
Psychotherapy, Brief | 1 | 2011 | 118 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2000 | 1841 | 0.020 |
Why?
|
Hawaii | 1 | 2010 | 102 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2000 | 1792 | 0.020 |
Why?
|
Antigens, CD | 1 | 2021 | 4003 | 0.020 |
Why?
|
Trans-Activators | 1 | 2000 | 2856 | 0.020 |
Why?
|
Carboplatin | 1 | 2013 | 794 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5789 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2643 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1750 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1596 | 0.020 |
Why?
|
Transcription Factors | 2 | 2022 | 12128 | 0.020 |
Why?
|
Burnout, Professional | 1 | 1998 | 704 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2023 | 11076 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 1999 | 2469 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3602 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2013 | 675 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2013 | 907 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2009 | 56 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2010 | 386 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2008 | 69 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 519 | 0.020 |
Why?
|
Weight Gain | 1 | 2019 | 2348 | 0.020 |
Why?
|
Pregnancy Rate | 1 | 2011 | 648 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.020 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 74 | 0.020 |
Why?
|
Binding Sites | 2 | 2011 | 6055 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7048 | 0.020 |
Why?
|
Caspase 8 | 1 | 2008 | 190 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2014 | 1460 | 0.020 |
Why?
|
Overweight | 1 | 2019 | 2417 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5791 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 214 | 0.020 |
Why?
|
Protein Binding | 2 | 2015 | 9351 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 1374 | 0.020 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 244 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2122 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2011 | 764 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3358 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17635 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2134 | 0.020 |
Why?
|
Animals | 4 | 2017 | 168459 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2023 | 64680 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2416 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3728 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10445 | 0.020 |
Why?
|
Paclitaxel | 1 | 2013 | 1732 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4575 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4853 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1858 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8465 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2008 | 656 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 698 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2008 | 672 | 0.010 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2008 | 629 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2014 | 2093 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2919 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1342 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20098 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1422 | 0.010 |
Why?
|
Anxiety | 1 | 2018 | 4573 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1134 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3518 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5774 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1135 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4320 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6132 | 0.010 |
Why?
|
Kinetics | 2 | 2000 | 6374 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6596 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8654 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1897 | 0.010 |
Why?
|
Preoperative Care | 1 | 2010 | 2242 | 0.010 |
Why?
|
Transaminases | 1 | 2002 | 198 | 0.010 |
Why?
|
Biological Availability | 1 | 2002 | 390 | 0.010 |
Why?
|
Chromatin | 1 | 2013 | 2960 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4615 | 0.010 |
Why?
|
Half-Life | 1 | 2002 | 651 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16591 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
Leucine Zippers | 1 | 2000 | 116 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2000 | 344 | 0.010 |
Why?
|
Emotions | 1 | 2011 | 2739 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1999 | 321 | 0.010 |
Why?
|
Catalysis | 1 | 2000 | 774 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1999 | 411 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6845 | 0.010 |
Why?
|
Tennessee | 1 | 1998 | 120 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5840 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18252 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 891 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12441 | 0.010 |
Why?
|
Students, Nursing | 1 | 1998 | 46 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42230 | 0.010 |
Why?
|
New York | 1 | 2000 | 874 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.010 |
Why?
|
Safety | 1 | 2002 | 1150 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2219 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2000 | 1229 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1791 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1999 | 736 | 0.010 |
Why?
|
Protein Folding | 1 | 2000 | 870 | 0.010 |
Why?
|
Asthma | 1 | 2015 | 6234 | 0.010 |
Why?
|
Organizational Policy | 1 | 1998 | 432 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1405 | 0.010 |
Why?
|
Oligopeptides | 1 | 2000 | 1187 | 0.010 |
Why?
|
Blotting, Western | 1 | 2002 | 5035 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1999 | 1527 | 0.010 |
Why?
|
Needs Assessment | 1 | 1998 | 1139 | 0.010 |
Why?
|
Antibodies | 1 | 1999 | 2418 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6534 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81525 | 0.010 |
Why?
|
Models, Molecular | 1 | 2000 | 5439 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 26198 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13446 | 0.000 |
Why?
|
Infant | 1 | 2009 | 36192 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1999 | 4544 | 0.000 |
Why?
|
Patient Selection | 1 | 1999 | 4244 | 0.000 |
Why?
|
Rats | 1 | 2000 | 23742 | 0.000 |
Why?
|
Medicare | 1 | 2000 | 6770 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1998 | 7879 | 0.000 |
Why?
|